Schedule 13G ownership disclosure

ANI Pharmaceuticals Inc

Common Stock · CUSIP: 00182C103

Event date: 2025-09-30

Filing-level shares
2,517,424
Percent of class
11.3%
  • BlackRock, Inc.

    Shares: 2,517,424 · Class: 11.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002012383-25-002486
Form type
SCHEDULE 13G/A
Filer
ANI PHARMACEUTICALS INC
CIK
CIK 1023024
Filed
Oct 17, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub